Anavex Life Sciences reported positive phase 2 results for ANAVEX 3-71 in schizophrenia. Read my analysis on AVXL stock here.
Scality and Inria aim to revolutionize storage security and sustainability through artificial intelligencePARIS and SAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback